Literature DB >> 28763067

[Myocardial infarction in young mexicans associated to metabolic syndrome].

Álvaro Mathiew-Quirós1, Ana María Salinas-Martínez1, Francisco Javier Guzmán de la Garza1, María Guadalupe Garza-Sagástegui2, Nancy Elena Guzmán-Delgado3, Magda Graciela Palmero-Hinojosa1, Norma Edith Oliva-Sosa1.   

Abstract

BACKGROUND: Acute coronary diseases are catastrophic, especially in young patients.
OBJECTIVE: To determine the risk of metabolic syndrome (MS) for premature acute myocardial infarction (AMI), combined with familial, behavioral, and nutritional factors in the northeast of Mexico.
MATERIAL AND METHODS: This is a case control study of patients less than 47 years of age with no personal history of angina, AMI, or cerebrovascular disease. Cases corresponded to patients with AMI (incident and primary cases; n = 55) and controls were blood donors located at the same hospital (n = 55). Behavioral, nutritional, and cardiometabolic risk factors were measured. Multivariate logistic regression was used for estimating odds ratios (OR) and 95% confidence intervals (95% CI).
RESULTS: MS increased the risk for premature AMI (95% CI: 1.73-39.5) eightfold, followed by smoking (OR: 7.76; 95% CI: 1.27-47.3), family history of AMI or sudden death (OR: 11.0; 95% CI: 2.03-60.4), and sedentary lifestyle (OR: 2.26; 95% CI: 2.52-9.80), independent of potential confounders.
CONCLUSIONS: The study highlights the magnitude of the risk of MS for AMI in Mexican young adults. The phenomenon of coronary diseases among young adults needs essential attention from the health sector.

Entities:  

Mesh:

Year:  2017        PMID: 28763067

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  2 in total

1.  MiR-467a-5p aggravates myocardial infarction by modulating ZEB1 expression in mice.

Authors:  Wei Huang; Yu Cao; Chenyang Chen; Xi Wu; Zhe Sheng; Anying Li
Journal:  J Mol Histol       Date:  2021-05-17       Impact factor: 2.611

2.  MIF mRNA Expression and Soluble Levels in Acute Coronary Syndrome.

Authors:  Emmanuel Valdés-Alvarado; Yeminia Valle; José Francisco Muñoz-Valle; Ilian Janet García-Gonzalez; Angelica Valdez-Haro; Hector Enrique Flores-Salinas; Jorge Manuel Pérez-Ibarra; Elena Sandoval-Pinto; Jorge Ramón Padilla-Gutiérrez
Journal:  Cardiol Res Pract       Date:  2018-07-02       Impact factor: 1.866

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.